351 related articles for article (PubMed ID: 6039969)
21. Steric aspects of adrenergic drugs. XX. Accumulation of (-)- and (+)-norepinephrine- 14 C by peripheral tissues of the rat.
Krell RD; Patil PN
J Pharmacol Exp Ther; 1972 Aug; 182(2):273-83. PubMed ID: 5048364
[No Abstract] [Full Text] [Related]
22. The effect of monoamine oxidase inhibition on guanethidine-induced noradrenaline release and sympathetic blockade.
Fielden R; Green AL
J Pharm Pharmacol; 1965 Jul; 17(7):463-4. PubMed ID: 4379272
[No Abstract] [Full Text] [Related]
23. Blocking H 3 -Norepinephrine uptake and some guanethidine-induced effects with tricyclic psychotherapeutic drugs.
Koe BK; Constantine JW
Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):71-80. PubMed ID: 5010834
[No Abstract] [Full Text] [Related]
24. [Pharmacological effects of [(octahydro-2-azocinyl)methyl] guanidine(guanazodine): its action mechanism and hypotensive effect].
Shimizu T; Hamakawa H; Tozuka T; Ono H
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):837-50. PubMed ID: 1035187
[TBL] [Abstract][Full Text] [Related]
25. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].
Kroneberg G; Schlossmann K; Stoepel K
Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784
[No Abstract] [Full Text] [Related]
26. Some direct and indirect sympathomimetic actions of metaraminol.
Stone CA; Stavorski JM; Ludden CT; Wenger HC; Torchiana ML
Arch Int Pharmacodyn Ther; 1966 May; 161(1):49-60. PubMed ID: 5941882
[No Abstract] [Full Text] [Related]
27. Inhibitory effects of clonidine and BS 100-141 on responses to sympathetic nerve stimulation in cats and rabbits.
Pacha W; Salzmann R; Scholtysik G
Br J Pharmacol; 1975 Apr; 53(4):513-6. PubMed ID: 1148494
[TBL] [Abstract][Full Text] [Related]
28. Distribution of guanidinium antihypertensives--mechanism of their selective action.
Oates JA; Mitchell JR; Feagin OT; Kaufmann JS; Shand DG
Ann N Y Acad Sci; 1971 Jul; 179():302-9. PubMed ID: 5285379
[No Abstract] [Full Text] [Related]
29. Supersensitivity to norepinephrine induced by continuous nerve stimulation.
Trendelenburg U
J Pharmacol Exp Ther; 1966 Jan; 151(1):95-102. PubMed ID: 5902184
[No Abstract] [Full Text] [Related]
30. Antihypertensive and noradrenaline-depleting effects of guanethidine metabolites.
Maître L; Staehelin M; Brunner H
J Pharm Pharmacol; 1971 May; 23(5):327-31. PubMed ID: 4102689
[No Abstract] [Full Text] [Related]
31. [Effect of 2-amino-4,5,6,7-tetrahydro-5-propyl-thiazole(5,4-c)pyridine, an antihypertensive and sedative substance, on the noradrenaline storage in the heart of guinea pigs].
Honjo T; Engelhardt G
Arzneimittelforschung; 1970 Jun; 20(6):845-50. PubMed ID: 5468901
[No Abstract] [Full Text] [Related]
32. Release of catecholamine from the cat heart by some directly and indirectly acting sympathomimetic amines.
Kaul CL; Grewal RS
Biochem Pharmacol; 1971 Aug; 20(8):1787-95. PubMed ID: 5137946
[No Abstract] [Full Text] [Related]
33. Potentiation of tyramine responses by nor-sympathomimetic amines in the reserpine-pretreated cat.
Murnaghan MF
Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):332-55. PubMed ID: 5841189
[No Abstract] [Full Text] [Related]
34. The antagonism by atropine of the response of the nictitating membrane to sympathetic nerve stimulation.
Reas HW; Tsai TH
J Pharmacol Exp Ther; 1966 May; 152(2):186-96. PubMed ID: 5949743
[No Abstract] [Full Text] [Related]
35. The effects of drugs on noradrenaline and dense-cored vesicles in ligated post-ganglionic sympathetic nerves in vitro.
Banks P; Mayor D; Tomlinson DR
J Physiol; 1972 Apr; 222(1):72P-73P. PubMed ID: 4338693
[No Abstract] [Full Text] [Related]
36. Pharmacological action of octopamine with special reference to biochemical conversion to noradrenaline.
Fujiwara M; Hattori K; Mizusawa H; Muryobayashi T; Kato Y
Jpn J Pharmacol; 1968 Mar; 18(1):113-29. PubMed ID: 4876760
[No Abstract] [Full Text] [Related]
37. The effects of alpha-methyldopa, reserpine, guanethidine, and iproniazid on minimum alveolar anesthetic requirement (MAC).
Miller RD; Way WL; Eger EI
Anesthesiology; 1968; 29(6):1153-8. PubMed ID: 5726752
[No Abstract] [Full Text] [Related]
38. The release of noradrenaline from sympathetic fibres in relation to calcium concentration.
Burn JH; Gibbons WR
J Physiol; 1965 Nov; 181(1):214-23. PubMed ID: 5866284
[No Abstract] [Full Text] [Related]
39. Cholinergic link hypothesis and sympathetic transmission at the nictitating membrane of the dog.
Arya PC; Gulati OD
Br J Pharmacol Chemother; 1968 Jul; 33(3):413-25. PubMed ID: 4302567
[No Abstract] [Full Text] [Related]
40. Reserpine-resistant responses to nerve stimulation in the cat nictitating membrane involve the release of newly synthesized noradrenaline.
Duval N; Hicks PE; Langer SZ
Eur J Pharmacol; 1986 Mar; 122(1):93-101. PubMed ID: 2869963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
